ArcticZymes Technologies ASA (B4V.F)

2,0750 -0,0150 (-0,72%) Börsenschluss: 09:11AM CEST

ArcticZymes Technologies ASA

SIVA Innovation Centre
Sykehusveien 23
Tromsø 9294
Norway
47 77 64 89 00
https://www.arcticzymes.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 61

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Michael Benjamin Akoh	Chief Executive Officer	59,6k	N/A	1973
Mr. Borge Sorvoll	Chief Financial Officer	162,77k	N/A	1975
Dr. Marit Sjo Lorentzen	Vice President of Operations	118,95k	N/A	1968
Mr. Dirk Hahneiser	Vice President of Business Development & Marketing	178,44k	N/A	1968
Dr. Jeremy Gillespie	Vice President of Corp. Dev & Prod. mgt	122,76k	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; double-strand specific DNases and derived kits for the removal of double stranded DNA; DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It serves the molecular tools research and diagnostics, and biomanufacturing markets. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Corporate Governance

ArcticZymes Technologies ASAs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.